PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-45.31%
Negative revenue growth while 9698.HK stands at 10.60%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-27.69%
Negative gross profit growth while 9698.HK is at 7.47%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-176.24%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-168.14%
Negative net income growth while 9698.HK stands at 4.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-168.17%
Negative EPS growth while 9698.HK is at 5.91%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-168.17%
Negative diluted EPS growth while 9698.HK is at 5.91%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 9698.HK is at 1.39%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 9698.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
234.80%
Positive OCF growth while 9698.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
234.11%
Positive FCF growth while 9698.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-80.43%
Negative 10Y revenue/share CAGR while 9698.HK stands at 520.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-81.30%
Negative 5Y CAGR while 9698.HK stands at 520.60%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-84.60%
Negative 3Y CAGR while 9698.HK stands at 78.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
546.56%
10Y OCF/share CAGR above 1.5x 9698.HK's 350.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
10.14%
Below 50% of 9698.HK's 350.58%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
411.16%
3Y OCF/share CAGR above 1.5x 9698.HK's 223.29%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-115.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-132.26%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-244.87%
Negative 3Y CAGR while 9698.HK is 29.61%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
9.09%
Below 50% of 9698.HK's 451.27%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.06%
Negative 5Y equity/share growth while 9698.HK is at 451.27%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-9.76%
Negative 3Y equity/share growth while 9698.HK is at 62.99%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-46.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-59.01%
Inventory is declining while 9698.HK stands at 28.40%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.50%
Negative asset growth while 9698.HK invests at 12.46%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.06%
We have a declining book value while 9698.HK shows 7.42%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-5.22%
We’re deleveraging while 9698.HK stands at 8.95%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.73%
SG&A declining or stable vs. 9698.HK's 16.25%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.